169 related articles for article (PubMed ID: 2538337)
1. Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1.
Hoosein NM; McKnight MK; Levine AE; Mulder KM; Childress KE; Brattain DE; Brattain MG
Exp Cell Res; 1989 Apr; 181(2):442-53. PubMed ID: 2538337
[TBL] [Abstract][Full Text] [Related]
2. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
Hébert CD; Birnbaum LS
Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899
[TBL] [Abstract][Full Text] [Related]
3. Modulation of differentiation and proliferation in human colon carcinoma cells by transforming growth factor beta 1 and beta 2.
Chakrabarty S; Fan D; Varani J
Int J Cancer; 1990 Sep; 46(3):493-9. PubMed ID: 1697568
[TBL] [Abstract][Full Text] [Related]
4. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta.
Chakrabarty S; Jan Y; Brattain MG; Tobon A; Varani J
Cancer Res; 1989 Apr; 49(8):2112-7. PubMed ID: 2539253
[TBL] [Abstract][Full Text] [Related]
5. Biological effects and binding properties of transforming growth factor-beta on human oral squamous cell carcinoma cells.
Ichijo H; Momose F; Miyazono K
Exp Cell Res; 1990 Apr; 187(2):263-9. PubMed ID: 2156718
[TBL] [Abstract][Full Text] [Related]
6. Effects of N,N-dimethylformamide and extracellular matrix on transforming growth factor-beta binding to a human colon carcinoma cell line.
Levine AE; Black B; Brattain MG
J Cell Physiol; 1989 Mar; 138(3):459-66. PubMed ID: 2925796
[TBL] [Abstract][Full Text] [Related]
7. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the inhibitory effects of transforming growth factor-beta on a human colon carcinoma cell line.
Hoosein NM; Brattain DE; McKnight MK; Levine AE; Brattain MG
Cancer Res; 1987 Jun; 47(11):2950-4. PubMed ID: 3471320
[TBL] [Abstract][Full Text] [Related]
9. Clonal heterogeneity of the sensitivity of human colon carcinoma cell lines to TGE beta isoforms.
Zhou GH; Sechrist GL; Brattain MG; Mulder KM
J Cell Physiol; 1995 Dec; 165(3):512-20. PubMed ID: 7593230
[TBL] [Abstract][Full Text] [Related]
10. Clonal stimulation or inhibition of human colon carcinomas and human renal carcinomas mediated by transforming growth factor-beta 1.
Fan D; Chakrabarty S; Seid C; Bell CW; Schackert H; Morikawa K; Fidler IJ
Cancer Commun; 1989; 1(2):117-25. PubMed ID: 2561734
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta isoform-specific differences in interactions with type I and II transforming growth factor beta receptors.
Zhou GH; Sechrist GL; Periyasamy S; Brattain MG; Mulder KM
Cancer Res; 1995 May; 55(10):2056-62. PubMed ID: 7743502
[TBL] [Abstract][Full Text] [Related]
12. Alterations of the biological characteristics of a colon carcinoma cell line by colon-derived substrata material.
Boyd D; Florent G; Chakrabarty S; Brattain D; Brattain MG
Cancer Res; 1988 May; 48(10):2825-31. PubMed ID: 3162826
[TBL] [Abstract][Full Text] [Related]
13. Role of transforming growth factor beta 1 in induction of colon carcinoma differentiation by hexamethylene bisacetamide.
Schroy P; Rifkin J; Coffey RJ; Winawer S; Friedman E
Cancer Res; 1990 Jan; 50(2):261-5. PubMed ID: 2295065
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the antiproliferative effects of transforming growth factor-beta, N,N-dimethylformamide and retinoic acid on a human colon carcinoma cell line.
Hoosein NM; Brattain DE; McKnight MK; Childress KE; Chakrabarty S; Brattain MG
Cancer Lett; 1988 Jun; 40(2):219-32. PubMed ID: 3164250
[TBL] [Abstract][Full Text] [Related]
15. Expression of TGF-alpha/EGF and TGF-beta receptors in human colon carcinoma cell lines.
Murthy U; Anzano MA; Greig RG
Int J Cancer; 1989 Jul; 44(1):110-5. PubMed ID: 2545633
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta inhibits the growth of renal cell carcinoma in vitro.
Gomella LG; Sargent ER; Linehan WM; Kasid A
J Urol; 1989 May; 141(5):1240-4. PubMed ID: 2540353
[TBL] [Abstract][Full Text] [Related]
17. Induction of carcinoembryonic antigen secretion and modulation of protein secretion/expression and fibronectin/laminin expression in human colon carcinoma cells by transforming growth factor-beta.
Chakrabarty S; Tobon A; Varani J; Brattain MG
Cancer Res; 1988 Jul; 48(14):4059-64. PubMed ID: 3289738
[TBL] [Abstract][Full Text] [Related]
18. Characterization of transforming growth factor-beta-resistant subclones isolated from a transforming growth factor-beta-sensitive human colon carcinoma cell line.
Mulder KM; Ramey MK; Hoosein NM; Levine AE; Hinshaw XH; Brattain DE; Brattain MG
Cancer Res; 1988 Dec; 48(24 Pt 1):7120-5. PubMed ID: 3191488
[TBL] [Abstract][Full Text] [Related]
19. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
[TBL] [Abstract][Full Text] [Related]
20. Possible involvement of TGF beta 1 in the distinct tumorigenic properties of two rat colon carcinoma clones.
Grégoire M; Garrigue L; Blottière HM; Denis MG; Meflah K
Invasion Metastasis; 1992; 12(3-4):185-96. PubMed ID: 1338201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
